You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰恩康(301263.SZ):利丙雙卡因乳膏收到藥品註冊受理通知書

格隆匯4月30日丨泰恩康(301263.SZ)公佈,全資子公司廣東泰恩康製藥廠有限公司於近日收到國家藥品監督管理局簽發的利丙雙卡因乳膏境內生產藥品註冊上市許可申請《受理通知書》,國家藥監局根據《中華人民共和國行政許可法》第三十二條的規定,對上述藥品的藥品註冊上市許可申請進行了審查,決定予以受理。利丙雙卡因乳膏是一種外用局部麻醉鎮痛製劑,適用於各類針穿刺和皮膚、黏膜淺層的外科手術麻醉。隨着生活水平的提高和醫療技術的發展,市場對於局部麻醉藥物的需求不斷增加。利丙雙卡因乳膏憑藉其便利、安全性高和無依賴性等優點,逐漸成爲臨牀淺表層麻醉用藥的新趨勢,廣泛適用於整形美容科、普外科、麻醉科、泌尿科、皮膚病科等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account